Recent Trends in Screening and Evaluation Methods of Anticancer Drugs
Journal Title: Indo American Journal of Pharmaceutical Research - Year 2012, Vol 2, Issue 4
Abstract
Cancer is one of the major life threatening diseases worldwide. The available anticancer drugs have distinct mechanisms of action which may vary in their effects on different types of normal and cancer cells. Screening methods are routinely and extensively used to reduce cost and time of drug discovery. The traditional anticancer drug screening methods, including animal experiments and cell-based screening assays. Screening methods for the detection of anticancer activity are of importance in order to find solid tumorspecific agents. The screening and evaluation procedures for the development of anticancer agents indicated that the entire process is a rather difficult task. Presently, active compounds are selected by prescreening and screening against transplanted mouse tumors and human tumor xenografts as well as by the in vitro systems. The US National Cancer Institute (NCI) 60 human tumour cell line anticancer drug screen (NCI60) was developed in the late 1980s as an in vitro drug-discovery tool intended to supplant the use of transplantable animal tumours in anticancer drug screening. This screening model give information about the mechanisms of growth inhibition and tumour-cell kill. Recently, its role has changed to that of a service screen supporting the cancer research community. Target-based and cell-based screenings for new anticancer drugs in the molecular targeting period are methods of identifying more selective anticancer drugs. Here I review the development, use and productivity of the screen, highlighting several outcomes that have contributed to advances in cancer chemotherapy. Finally, we discuss primary and secondary in vivo evaluation in experimental chemotherapy.
Authors and Affiliations
C. P Rathod, S. C. Dhawale, R. V. Kshirsagar
COMPARATIVE PHARMACOGNOSTICAL AND PHYSICO-CHEMICAL PROFILE OF ROOT OF IXORA COCCINEA LINN AND IXORA ARBOREA ROXB.
Abstract Ixora arborea Roxb. and Ixora coccinea Linn are belonging to the same family Rubiaceae. Both the plants are medium sized perennial shrub from 6 to 8 feet in height; Large bunches terminal tricotomously cymes. I....
CURRENT PERSPECTIVE ON NOVEL DELIVERY SYSTEM FOR MANAGEMENT ON NON-SMALL CELL LUNGS CANCER: COMPREHENSIVE REVIEW
Abstract Non-small cell lung cancer (NSCLC) is a type of lung cancer and presently a prominent cause for death among the cancer cases globally. It includes adenocarcinoma, squamous cell carcinoma and large cell carcinoma...
MICROWAVE GENERATED BIONANOCOMPOSITES FOR SOLUBILITY AND DISSOLUTION RATE ENHANCEMENT OF POORLY WATER SOLUBLE DRUG SIMVASTATIN
Abstract Fairly soluble drugs in gastrointestinal (GI) media exhibit complete oral absorption, and thus good bioavailability. About 40% of drugs are not soluble in water in practice and therefore are slowly absorbed, whi...
DEVELOPMENT OF HERBAL FORMULATION WITH AJWA SEED (Phoenix dactylifera L.) EXTRACT AND ZAM-ZAM WATER FOR ANTICANCER ACTIVITY
Fruits of the date palm (Phoenix dactylifera L.) Belonging to the family of Arecaceae are very commonly consumed in many parts of the world and are a vital component of the diet in most of the Arabian countries. One of t...
THE SCREENING OF HERBALS AS IMMUNOMODULATORS IN THERAPEUTICS: A REVIEW
Immune system is a network of biological structure and processes that does a remarkable job of defending the body against foreign invaders and any kind of impairment in its development or functioning leads to various dis...